Reversible Ocular Toxicity of Oxaliplatin: A Case Report

Oxaliplatin, a platinum-based chemotherapy agent, is commonly used in the treatment of various malignancies. Common adverse effects involve neurological, hematological, gastrointestinal system, and hypersensitivity, and rarely ocular changes have also been reported. We describe the case of a 71-year...

Descripción completa

Detalles Bibliográficos
Autores principales: Noor, Arish, Desai, Aakash, Singh, Meghana
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cureus 2019
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6605969/
https://www.ncbi.nlm.nih.gov/pubmed/31293842
http://dx.doi.org/10.7759/cureus.4582
_version_ 1783431843714957312
author Noor, Arish
Desai, Aakash
Singh, Meghana
author_facet Noor, Arish
Desai, Aakash
Singh, Meghana
author_sort Noor, Arish
collection PubMed
description Oxaliplatin, a platinum-based chemotherapy agent, is commonly used in the treatment of various malignancies. Common adverse effects involve neurological, hematological, gastrointestinal system, and hypersensitivity, and rarely ocular changes have also been reported. We describe the case of a 71-year-old male, who developed reversible ocular toxicity after receiving oxaliplatin for treatment for pancreatic cancer. 
format Online
Article
Text
id pubmed-6605969
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher Cureus
record_format MEDLINE/PubMed
spelling pubmed-66059692019-07-10 Reversible Ocular Toxicity of Oxaliplatin: A Case Report Noor, Arish Desai, Aakash Singh, Meghana Cureus Oncology Oxaliplatin, a platinum-based chemotherapy agent, is commonly used in the treatment of various malignancies. Common adverse effects involve neurological, hematological, gastrointestinal system, and hypersensitivity, and rarely ocular changes have also been reported. We describe the case of a 71-year-old male, who developed reversible ocular toxicity after receiving oxaliplatin for treatment for pancreatic cancer.  Cureus 2019-05-01 /pmc/articles/PMC6605969/ /pubmed/31293842 http://dx.doi.org/10.7759/cureus.4582 Text en Copyright © 2019, Noor et al. http://creativecommons.org/licenses/by/3.0/ This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
spellingShingle Oncology
Noor, Arish
Desai, Aakash
Singh, Meghana
Reversible Ocular Toxicity of Oxaliplatin: A Case Report
title Reversible Ocular Toxicity of Oxaliplatin: A Case Report
title_full Reversible Ocular Toxicity of Oxaliplatin: A Case Report
title_fullStr Reversible Ocular Toxicity of Oxaliplatin: A Case Report
title_full_unstemmed Reversible Ocular Toxicity of Oxaliplatin: A Case Report
title_short Reversible Ocular Toxicity of Oxaliplatin: A Case Report
title_sort reversible ocular toxicity of oxaliplatin: a case report
topic Oncology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6605969/
https://www.ncbi.nlm.nih.gov/pubmed/31293842
http://dx.doi.org/10.7759/cureus.4582
work_keys_str_mv AT noorarish reversibleoculartoxicityofoxaliplatinacasereport
AT desaiaakash reversibleoculartoxicityofoxaliplatinacasereport
AT singhmeghana reversibleoculartoxicityofoxaliplatinacasereport

Ejemplares similares